0.8879
Jaguar Health Inc Aktie (JAGX) Neueste Nachrichten
Is Jaguar Health Inc stock showing strong momentumJuly 2025 Action & Real-Time Sentiment Analysis - baoquankhu1.vn
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - The Coloradoan
JAGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference - 富途牛牛
Jaguar Health (JAGX) Announces Special Stock Dividend with Conve - GuruFocus
Jaguar Declares Special Stock Dividend to Protect Shareholders - Intellectia AI
Jaguar Health Declares Special Convertible Preferred Stock Dividend - TipRanks
Jaguar Health to Pay Special Stock Dividend - marketscreener.com
Jaguar Health Announces a Special One-time Stock Dividend - ACCESS Newswire
Hedge Fund Moves: Should value investors consider Jaguar Health IncJuly 2025 Volume & AI Driven Stock Price Forecasts - baoquankhu1.vn
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Treasure Coast News
Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, March 6th, During the Western Veterinary Conference (WVC) in Las Vegas - ACCESS Newswire
Is Jaguar Health Inc. stock a safe buy before earningsQuarterly Investment Review & AI Based Trade Execution Alerts - mfd.ru
Will Jaguar Health Inc. benefit from current market trendsGap Up & Low Risk Investment Opportunities - mfd.ru
Bull Bear: Is Howard Hughes Holdings Inc a cyclical or defensive stockJuly 2025 Final Week & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Is Jaguar Health Inc. undervalued by DCF analysisWeekly Trade Summary & High Win Rate Trade Tips - mfd.ru
Is Jaguar Health Inc. stock showing strong momentum2025 Big Picture & Weekly High Return Stock Opportunities - mfd.ru
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY - TradingView
Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million - Marco Eagle
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts - The Marion Star
Should value investors consider Jaguar Health Inc.July 2025 Opening Moves & Weekly Breakout Watchlists - mfd.ru
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - hattiesburgamerican.com
Jaguar Health Executes Debt-Reducing Equity Warrant Transactions - TipRanks
Jaguar Health Signs Multiple Material Agreements - TradingView
Jaguar Health (JAGX) Advances Rare Disease Program with Focus on Crofelemer - GuruFocus
Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi - Lansing State Journal
Jaguar trial cuts children’s IV support needs by up to 37% - Stock Titan
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - barnstablepatriot.com
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Pueblo Chieftain
Earnings Report: Is Jaguar Health Inc a defensive stock2025 Valuation Update & Scalable Portfolio Growth Ideas - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):